The impact of topical finasteride on male-pattern baldness

Phase 1

• Conditions: Androgenic alopecia.; Androgenic alopecia

• Registration Number: IRCT201202048917N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Inclusion criterion: (to have androgenic alopecia of any type)
Exclusion criteria: (to be pregnant; to have non-androgenic alopecia in other regions of the body; to have signs of allergy to finasteride)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of lost hair. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Using hair loss test.;Hair diameter. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Using a micrometer under a microscope.;Type of androgenic alopecia. Timepoint: Before the initiation of the treatment and 3, 6, 9 and 12 month after the initiation of the treatment. Method of measurement: Based on protocol.